Form D · Manufacturing

Oboro Labs, Inc.

Delray Beach, FL · CIK 0002146682

Offering snapshot reported Jul 28, 2026 · SEC filing

Reported sold
$1.28M
Offering amount: $3.5M
Investors reported
16
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Dec 30, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 28, 2026Initial$1,275,000No comparison16SEC filing

Offering details

Securities
Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-592359

Source: Form D, filed Jul 28, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gregory Kis Director, Executive
Adam Veige Director

Issuer details

Industry: Manufacturing (See others in industry)

Address:
16765 Bridge Crossing Circle
Delray Beach, FL, 33446
Phone: 5618707251